Trozel

Trozel (Letrozole) is an oral prescription medication used primarily for hormone receptor-positive breast cancer in postmenopausal women. It belongs to the aromatase inhibitor class, helping reduce estrogen levels. This product is manufactured by Glenmark Pharmaceuticals S.R.O. and is available for oral use.

Trozel (Letrozole) is commonly prescribed to treat hormone receptor-positive breast cancer in postmenopausal women. It works by lowering estrogen levels in the body, which can slow or stop the growth of certain breast cancers. Some doctors may also prescribe it for off-label uses such as fertility treatment in women undergoing ovulation induction.

Trozel (Letrozole) helps regulate hormone levels in the body, which may reduce symptoms associated with high estrogen in certain conditions. Users may experience changes in energy levels or general well-being as the medication takes effect. Individual responses can vary based on medical history and treatment goals.

Trozel (Letrozole) should be taken exactly as prescribed by a healthcare professional. It is important to discuss your full medical history, including bone health and cholesterol levels, before starting this medication. Regular monitoring may be recommended to assess treatment progress and manage potential side effects.

Trozel (Letrozole) may interact with other medications, including hormone therapies and certain antidepressants. Alcohol use should be discussed with a doctor, as it may affect how the medication works. Always inform your healthcare provider about all prescription, over-the-counter, and herbal products you are taking.